Diabetes Management in Chronic Kidney Disease
Publication Date: October 1, 2020
Last Updated: July 31, 2022
Recommendations
Comprehensive care in patients with diabetes and CKD
Renin–angiotensin system (RAS) blockade
We recommend that treatment with an angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin II receptor blocker (ARB) be initiated in patients with diabetes, hypertension, and albuminuria, and that these medications be titrated to the highest approved dose that is tolerated. (Level 1, B)
312054
Smoking cessation
We recommend advising patients with diabetes and CKD who use tobacco to quit using tobacco products. (Level 1, D)
312054
Title
Diabetes Management in Chronic Kidney Disease
Authoring Organizations
Kidney Disease Improving Global Outcomes
National Kidney Foundation